Inbiomotion

Read news on Inbiomotion with our app.

Read more in the app

Inbiomotion’s MAF Test® now available to early-stage breast cancer patients in the United States through NeoGenomics

Inbiomotion, the spin-off of IRB Barcelona and ICREA, has signed an agreement to take the MAF Test® to patients in South Korea - EurekAlert!